MedPath

Percutaneous Cryoablation Peripheral Lung Cancer

Not Applicable
Conditions
Lung Cancer
Registration Number
NCT02665390
Lead Sponsor
Shanghai Chest Hospital
Brief Summary

This study is focus on percutaneous cryoablation,which was for the treatment of medically inoperable Peripheral lung cancer.The patients who were agreed to attend the study will accept the operation. After the operations,they will follow up according to the plan.

Detailed Description

The patients who were agreed to attend the study conclude early stage lung cancer and solitary metastatic lung cancer.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
30
Inclusion Criteria

medically inoperable peripheral lung cancer Diameter no more than 3cm

Exclusion Criteria
  1. Refusal of participation
  2. tendency to bleed to that can't receive percutaneous cryoablation.
  3. Severe cardiopulmonary dysfunction and other indications that can't receive percutaneous cryoablation.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
PFS2 years
Secondary Outcome Measures
NameTimeMethod
OS2 years

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.